T-cell alloimmunity and chronic allograft dysfunction

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 64, Issue 6, Pages (December 2003)
Melamine toxicity: one more culprit in calcium kidney lithiasis
Transplant rejection: T-helper cell paradigm
Transplant Immunology and Immunosuppression: Core Curriculum 2015
Transplant: immunology and treatment of rejection
Michael D. Gautreaux, Barry I. Freedman  Kidney International 
Volume 78, Issue 2, Pages (July 2010)
Renal manifestations in Fabry disease and therapeutic options
Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs  Alberto Sánchez–Fueyo, Terry B. Strom  Gastroenterology 
Anemia management in chronic kidney disease
Volume 79, Issue 6, Pages (March 2011)
Germaine Wong, Jeremy R. Chapman, Jonathan C. Craig 
Volume 79, Issue 9, Pages (May 2011)
Mechanisms of Drug-Induced Allergy
Transplantation Rejection of foreign tissue grafts is due to immune responses to alloantigens on the graft Blood group antigens Polymorphic MHC antigens.
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Progression of renal failure and hypertensive nephrosclerosis
John P. Middleton, Patrick H. Pun  Kidney International 
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Robert J Korst, MD, Ronald G Crystal, MD 
Peritubular capillaritis in the renal allograft takes center stage
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
Volume 84, Issue 2, Pages (August 2013)
The Other Face of Chimeric Antigen Receptors
Infection and chronic allograft dysfunction
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Macrophages and dendritic cells: what is the difference?
Nephrology Crosswords: Hemodialysis
Volume 86, Issue 2, Pages (August 2014)
The epidemiology of chronic kidney disease
Harnessing regulatory T cells for therapeutic purposes
Dendritic cells and innate immunity in kidney transplantation
Melamine toxicity: one more culprit in calcium kidney lithiasis
Should kidney donors be genotyped for APOL1 risk alleles?
The management of CKD: A look into the future
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Calcium sensing in podocytes
Joshua D. Ooi, A. Richard Kitching  Kidney International 
Are calcineurin inhibitors-free regimens ready for prime time?
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Emerging role of B cells in chronic allograft dysfunction
Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson  Kidney International 
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 9, Pages (November 2012)
Volume 71, Issue 12, Pages (June 2007)
Nanocrystals seed calcification in more ways than one
Consequences of transplant quality on chronic allograft nephropathy
Volume 83, Issue 4, Pages (April 2013)
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Charles A. Herzog  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Gene targeting: Applications in transplantation research
Volume 75, Issue 7, Pages (April 2009)
Arya M. Sharma, Joachim Beige, Armin Distler  Kidney International 
Membranous nephropathy: recent travels and new roads ahead
Dendritic Cells in Transplantation—Friend or Foe?
Volume 64, Issue 6, Pages (December 2003)
T cells and T-cell receptors in acute renal failure
The international realities of live donor kidney transplantation
The International Pediatric Peritonitis Registry: Starting to walk
Volume 74, Issue 10, Pages (November 2008)
Global trends in the rates of living kidney donation
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

T-cell alloimmunity and chronic allograft dysfunction Niloufar Safinia, Behdad Afzali, Kerem Atalar, Giovanna Lombardi, Robert I. Lechler  Kidney International  Volume 78, Pages S2-S12 (December 2010) DOI: 10.1038/ki.2010.416 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Direct, indirect, and semidirect pathways of allorecognition. (a) In the direct pathway, intact major histocompatibility complex (MHC) on donor antigen-presenting cells (APCs) is recognized directly by recipient CD4+ and CD8+ T cells. (b) The indirect pathway is characterized by recipient APC uptake of allogeneic donor MHC that has been shed through apoptosis or necrosis. This is then processed, resulting in presentation of donor antigens in the context of recipient MHC class II to recipient CD4+ T cells. (c) Semidirect allorecognition results from the transfer of cellular membrane components, including intact donor MHC, from donor APCs to recipient APCs. This process may occur through mechanisms such as cell–cell contact or through the transfer of donor exosomes that fuse with recipient APC cell membranes. Recipient APCs are then chimeric for MHC, and are able to stimulate both CD4+ and CD8+ donor T cells. Kidney International 2010 78, S2-S12DOI: (10.1038/ki.2010.416) Copyright © 2010 International Society of Nephrology Terms and Conditions